mRNA vaccine development for cholangiocarcinoma: a precise pipeline

Cholangiocarcinoma (CHOL) is one of the most aggressive tumors worldwide and cannot be effectively treated by conventional and novel treatments, including immune checkpoint blockade therapy. The mRNA vaccine-based immunotherapeutic strategy has attracted much attention for various diseases, however,...

Descripción completa

Detalles Bibliográficos
Autores principales: Tang, Tian-Yu, Huang, Xing, Zhang, Gang, Lu, Ming-Hao, Liang, Ting-Bo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277828/
https://www.ncbi.nlm.nih.gov/pubmed/35821067
http://dx.doi.org/10.1186/s40779-022-00399-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9277828/
https://www.ncbi.nlm.nih.gov/pubmed/35821067
http://dx.doi.org/10.1186/s40779-022-00399-8

Ejemplares similares